What are the uses of Kidtecat?

This is an automatically translated article.


Kidtecat medicine 4mg belongs to the group of effects on the respiratory tract. Kidtecat is used in the prevention and treatment of chronic bronchial asthma; Relief of symptoms of allergic rhinitis in both adults and children over 2 years of age. The following article provides information for readers about dosage and notes when using Kidtecat.

1. What is Kidtecat?


Kidtecat medicine has the main ingredient Montelukast Sodium corresponding to Montelukast 4mg. Kidtecat is prepared in the form of nuggets.
Indications for taking Kidtecat 4mg drug in the following cases:
Prophylaxis and treatment of chronic bronchial asthma in adults and children from 6 months of age and older, including prophylaxis: Aspirin-sensitive asthma, symptoms day and night asthma, exercise-induced bronchospasm. Kidtecat is used to relieve daytime and nighttime symptoms of seasonal allergic rhinitis, and is used in adults and children 2 years of age and older. Kidtecat is also used in the treatment of year-round allergic rhinitis in adults and children 6 months of age and older. Contraindications to taking Kidtecat:
Hypersensitivity to Montelukast or any ingredient of Kidtecat.

2. How to take Kidtecat


How to use:
Kidtecat nuggets are given directly in the mouth or can be mixed with a spoonful of soft food to cool, or a spoon of milk at room temperature. Prophylaxis and treatment of chronic asthma: Take the drug in the evening.
Children from 6 months to 5 years old: Dosage 1 pack/time/day. Children from 6-14 years old: dose 1.5 sachets/time/day. Adults and children over 15 years: Dose 2.5 sachets/time/day. Exercise-induced bronchospasm: Administer 2 hours before strenuous activity.
Children from 6-14 years old: dose 1.5 sachets/time/day. Adults and children 15 years of age and older: Dose dose pack/time/day. Seasonal Allergic Rhinitis: The timing of administration depends on the needs of the patient.
Children from 2 to 5 years old: Dose 1 sachet/time/day. Children from 6-14 years old: dose 1.5 sachets/time/day. Adults and children 15 years of age and older: Dose 2.5 sachets/time/day. Perennial Allergic Rhinitis: The timing of administration depends on the needs of the patient.
Children from 6 months to 5 years old: Dose 1 pack/time/day. Children from 6-14 years old: Dose 1.5 sachets/time/day. Adults and children 15 years and older: 2.5 sachets/time/day. Bronchial asthma and allergic rhinitis: Use Kidtecat in the evening, the dose is adjusted depending on age.
Currently, research on the therapeutic effect of Montelukast in children under 2 years old is limited, so the drug should not be used in this population.
No dosage adjustment of Kidtecat is required for patients with mild to moderate renal or hepatic impairment.
Kidtecat overdose and treatment:
No specific treatment recommendations for Montelukast overdose. It is not known whether Montelukast can be eliminated by peritoneal dialysis or hemodialysis. In case of overdose of Kidtecat, go to a medical facility for timely treatment. Missing a dose of Kidtecat and what to do
If you forget to take a dose of Kidtecat, take it as soon as possible. If it is almost time for the next dose of Kidtecat, skip the missed dose and take the next dose as scheduled. Do not take a double dose of Kidtecat.

3. Undesirable effects of the drug Kidtecat


Some unwanted effects when using Montelukast:
Upper respiratory tract infections. Immune system: Hypersensitivity reactions, including anaphylaxis, hepatic eosinophilic infiltration have been reported rarely. Hematology: Increased bleeding, thrombocytopenia. Skin and subcutaneous tissue: Rash, pruritus, urticaria, angioedema, erythema multiforme. Psychiatric: Nightmares, insomnia, anxiety, hallucinations, agitation including aggressive behavior, hyperactivity, hypoesthesia, paresthesia and very rarely convulsions. Less common is attention disorder, memory impairment. Neurological, frequency unknown: Dizziness, seizures, lethargy, dreams. Gastrointestinal: Nausea, vomiting, diarrhea, dyspepsia, dry mouth, elevated liver enzymes (AST and ALT), hepatitis. Musculoskeletal, uncommon: Myalgia, arthralgia, cramps. Some other side effects: Fever, nosebleeds, Churg - Strauss syndrome, bleeding under the skin, palpitations, bedwetting in children. Inform your doctor if you experience unwanted effects while using Kidtecat.

4. Be careful when using Kidtecat


The effectiveness of Montelukast has not been established in the treatment of acute asthma attacks. Patients should be advised not to use oral Montelukast for acute asthma attacks, but to use other appropriate acute asthma medications.
Montelukast should not be abruptly substituted for inhaled or oral corticosteroids. There are no data recommending a reduction in the dose of oral corticosteroids when co-administered with Montelukast.
Montelukast should be used with caution in patients with neuropsychiatric conditions due to the risk of neuropsychiatric side effects. Carefully evaluate the risks and benefits of continuing treatment with Montelukast if the patient develops adverse effects on the nervous system.
Pregnant women: There are no adequate data on the use of Montelukast in pregnant women. Only use Kidtecat in this subject when absolutely necessary.
Lactation: Pharmacokinetic studies in rats have shown that montelukast is excreted in milk. Kidtecat should be used with caution in this population after a full assessment of the risks and benefits to the mother.
Ability to drive and use machines: Montelukast has little effect on the ability to drive and use machines. However, some cases of dizziness or drowsiness may occur when taking Montelukast.

5. Drug interactions


Kidtecat can be used concurrently with other drugs in the prevention and treatment of chronic bronchial asthma, allergic rhinitis. The recommended therapeutic dose of Kidtecat generally does not significantly affect the pharmacokinetics of the following drugs: Prednisone, Prednisolone, Theophylline, oral contraceptives, Terfenadine, Digoxin and Warfarin. The area under the curve for Montelukast is reduced by approximately 40% when co-administered with Phenobarbital. Above is all information about Kidtecat drug, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Note, Kidtecat is a prescription drug, patients need to use the drug as prescribed by the doctor, absolutely do not self-treat at home.

Share
Patients Stories